Clinical Trials Logo

Filter by:
NCT ID: NCT03725969 Completed - Insulin Sensitivity Clinical Trials

Effect of Camel Milk on Insulin and Incretin Response

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

To examine the differential effect of camel and cow milk on the physiological response, to a liquid mixed-meal challenge, in people with normal glucose tolerance

NCT ID: NCT03708991 Recruiting - Genetic Condition Clinical Trials

Effectiveness of PGT-A: IVF Versus ICSI

Start date: November 8, 2018
Phase:
Study type: Observational [Patient Registry]

The investigators want to investigate if the use of conventional in vitro fertilization (IVF) can generate more euploid embryos as compared to intracytoplasmic sperm injection (ICSI). To verify this, the investigators will inject half of the oocytes by ICSI and the other half of the oocytes will be inseminated by conventional IVF. The most important aim is to see if IVF is able to generate more euploid embryos.

NCT ID: NCT03703869 Recruiting - Diabetes Clinical Trials

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.

ATOS
Start date: March 6, 2018
Phase:
Study type: Observational

Primary Objective: Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c). Secondary Objectives: - Assess effectiveness in achieving glycemic goal measured by HbA1c; - Assess effectiveness on change in HbA1c, fasting plasma glucose (FPG) and self-monitored plasma glucose (SMPG) ; - Assess requirement for intensification of therapy by additional antidiabetics. - Assess incidence of hypoglycemia; - Assess other safety endpoints: adverse events (AEs), serious adverse events (SAEs); - Assess change in body weight.

NCT ID: NCT03686059 Recruiting - Clinical trials for Ocular Surface Disease

Outcome of Punctal Plugs on Ocular Surface Disease

Start date: July 2, 2018
Phase: Phase 4
Study type: Interventional

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs is simple procedure with good patient compliance for treatment of ocular surface disease associated with systemic isotretinoin therapy

NCT ID: NCT03644459 Not yet recruiting - Colorectal Cancer Clinical Trials

Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101

Start date: October 2, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is evaluate the pharmacokinetics, pharmacodynamics, immunogenicity and anti-tumor effect of of fully human anti - VEGF monoclonal antibody LY00101 and explore the potential prognostic and predictive biomarkers. This study will not take into account the results of molecular-genetic tests of patients enrolled in the study

NCT ID: NCT03636464 Recruiting - Clinical trials for Renal Replacement Therapy

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

RRTdose
Start date: April 1, 2018
Phase:
Study type: Observational

The study is aiming to describe the pharmacokinetic and pharmacodynamic profile of intravenous meropenem, ertapenem, cefepime, colistin, Ceftazidime/Avibactam , Ceftolozane/Tazobactam , and piperacillin/tazobactam in the plasma and determine how much is removed by Renal Replacement Therapies to ensure adequate dosing

NCT ID: NCT03607604 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE

Start date: April 1, 2015
Phase:
Study type: Observational

The study aims to investigate the validity of 2 hour post-prandial UCPCR test in paediatric and adult patients with diabetes duration greater than 2 and 5 years, respectively, for the purposes of distinguishing between patients with type 1 diabetes and MODY in the UAE population.

NCT ID: NCT03607409 Recruiting - Infertility Clinical Trials

Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

Start date: September 9, 2018
Phase:
Study type: Observational

To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol

NCT ID: NCT03597958 Recruiting - Clinical trials for Familial Hypercholesterolemia

Genetic Causes of Hypercholesterolaemia in the Emirati Population

Start date: January 17, 2017
Phase:
Study type: Observational

The scientific aims of the project are to understand the genetic basis of Familial Hypercholesterolaemia (FH) in the Emirati population and estimate the overall prevalence of the disease. In addition, a clinical aim of the project is to explore the effectiveness of screening the relatives of individuals affected by FH and other lipid disorders ("cascade" screening) within Emirati families.

NCT ID: NCT03590587 Recruiting - Clinical trials for Diabetic Macular Edema

Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates

Start date: January 13, 2017
Phase:
Study type: Observational

The Health Authority - Abu Dhabi (HAAD) approved the reimbursement of the slow release FAc implant (ILUVIEN) and it is now available for the treatment of diabetic macular edema (DME) in persons who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. We performed a retrospective 12-month audit to assess the efficacy and safety of the FAc implant in our clinical practice.